Method and apparatus for plasma surgery

• US 7,601,150 B2
• Filed: 06/20/2002
• Issued: 10/13/2009
• Est. Priority Date: 06/22/2001
• Status: Expired due to Fees

• Current Assignee: Erbe Elektromedizin GmbH (C. Erbe GmbH)
• Original Assignee: Erbe Elektromedizin GmbH (C. Erbe GmbH)
• Inventors: Farin, Günter
• Primary Examiner(s): Cohen; Lee S
• Application Number:
  US10/481,692
• Publication Number:
  US 20040181220A1
• Time in Patent Office: 2,672 Days
• Field of Search: 606/49, 606/40
• US Class Current: 606/40
• CPC Class Codes: A61B 18/042 using additional gas becoming plasma

Abstract

An apparatus for argon-plasma coagulation (APC) is disclosed, in which after activation of the apparatus for APC a specified amount of noble gas flows out of the APC instrument before the high-frequency voltage for ionizing the noble gas is switched on, or can be switched on. As a result an increase in safety is achieved.

Claims

1. A method of operating an apparatus for argon-plasma coagulation (APC), wherein the apparatus comprises at least a high-frequency source, a source of noble gas, and an APC instrument connected to the high-frequency source and to the source of the noble gas, and wherein the method comprises the following steps:

activating the apparatus for APC;

after activation of the apparatus for APC, causing a specified amount of noble gas to flow out of the APC instrument, thereby reducing the concentration of combustible substances near a biological tissue to be treated and thus avoiding the ignition of the combustible substances; and

after causing the specified amount of the noble gas to flow out of the APC instrument, allowing a high-frequency voltage for ionizing the noble gas to be switched on,

wherein the high-frequency voltage cannot be turned on as long as the specified amount of the noble gas has not flowed out of the APC instrument.

2. A method as claimed in claim 1, wherein the specified amount of the noble gas that flows out of the APC instrument before allowing the high-frequency voltage to be switched on can be adjusted in advance.

3. A method as claimed in claim 1, wherein the specified amount of the noble gas that flows out of the APC instrument before allowing the high-frequency voltage to be switched on is dependent on variable boundary conditions.

4. A method as claimed in claim 3, wherein the specified amount of the noble gas that flows out of the APC instrument before allowing the high-frequency voltage to be switched on is greater, the longer a pause between two periods of activation and/or the shorter preceding periods of activation have been.

5. A method as claimed in claim 1, further comprising, during a time interval from activation of the apparatus for argon-plasma coagulation (APC) until the high-frequency voltage is turned on, generating at least one of an acoustic and a visual signal, which informs the user that the high-frequency voltage is not yet turned on, or that it cannot yet be turned on.

6. An apparatus for argon-plasma coagulation (APC), comprising:

a high-frequency source;

a source of noble gas;

an argon-plasma coagulation instrument connected to the high-frequency source and to the source of the noble gas to conduct a coagulation current from the high-frequency source into the gas and through the gas into biological tissue to coagulate the tissue;

a controllable gas valve attached to the noble gas source;

at least one gas-flow sensor for determining a flow rate of the noble gas from the source; and

control means for controlling the flow rate of the noble gas from the noble gas source to the instrument such that, after activation of the apparatus, a specified amount of the noble gas must flow out of the instrument before the high-frequency source for ionizing the noble gas can be switched on, thereby reducing the concentration of combustible substances near a biological tissue to be treated and thus avoiding the ignition of the combustible substances,

wherein the control means is adapted to prevent the high-frequency source from being turned on until the specified amount of the noble gas has flowed out of the argon-plasma coagulation instrument.

7. An apparatus according to claim 6, wherein the control means can be adjusted in advance to control the amount of the noble gas that flows out of the argon-plasma coagulation instrument before the high-frequency source can be switched on.

8. A apparatus according to claim 6, wherein the control means is adapted to control the flow rate of the noble gas from the noble gas source to the instrument before the high-frequency source can be switched on, wherein the flow rate is dependent on relevant boundary conditions.

9. An apparatus according to claim 6, wherein the control means is adapted to adjust the amount of the noble gas that can flow out of the argon-plasma coagulation instrument before the high-frequency source can be switched on, where the amount of the noble gas is dependent on a length of a pause between two periods of activation of the instrument and a length of preceding periods of activation of the instrument.

10. An apparatus according to claim 6, comprising signaling means for generating a signal which informs the user that the high-frequency source is not turned on during a time interval between activation of the apparatus for coagulation and a turning on of the high-frequency source.

11. A method of operating an apparatus for argon-plasma coagulation (APC), wherein the apparatus comprises at least a high-frequency source, a source of noble gas, and an APC instrument connected to the high-frequency source and to the source of the noble gas, and wherein the method comprises the following steps:

activating the apparatus for APC;

after activation of the apparatus for APC, causing a specified amount of noble gas to flow out of the APC instrument, thereby reducing the concentration of combustible substances near a biological tissue to be treated and thus avoiding the ignition of the combustible substances; and

after causing the specified amount of the noble gas to flow out of the APC instrument, allowing a high-frequency voltage for ionizing the noble gas to be switched on,

wherein a flow rate at which the noble gas flows out of the APC instrument after activation of the apparatus but before the high-frequency voltage is turned on is higher than a flow rate at which the noble gas flows out of the APC instrument after the high-frequency voltage has been turned on during an APC procedure.

12. A method as claimed in claim 11, wherein the specified amount of the noble gas that flows out of the APC instrument before allowing the high-frequency voltage to be switched on can be adjusted in advance.

13. A method as claimed in claim 11, wherein the specified amount of the noble gas that flows out of the APC instrument before allowing the high-frequency voltage to be switched on is dependent on variable boundary conditions.

14. A method as claimed in claim 13, wherein the specified amount of the noble gas that flows out of the APC instrument before allowing the high-frequency voltage to be switched on is greater, the longer a pause between two periods of activation and/or the shorter preceding periods of activation have been.

15. A method as claimed in claim 11, further comprising, during a time interval from activation of the apparatus for argon-plasma coagulation (APC) until the high-frequency voltage is turned on, generating at least one of an acoustic and a visual signal, which informs the user that the high-frequency voltage is not yet turned on, or that it cannot yet be turned on.

16. A method as claimed in claim 11, wherein the high-frequency voltage cannot be turned on as long as the specified amount of the noble gas has not flowed out of the APC instrument.

17. An apparatus for argon-plasma coagulation (APC), comprising:

a high-frequency source;

a source of noble gas;

an argon-plasma coagulation instrument connected to the high-frequency source and to the source of the noble gas to conduct a coagulation current from the high-frequency source into the gas and through the gas into biological tissue to coagulate the tissue;

a controllable gas valve attached to the noble gas source;

at least one gas-flow sensor for determining a flow rate of the noble gas from the source; and

control means for controlling the flow rate of the noble gas from the noble gas source to the instrument such that, after activation of the apparatus, a specified amount of the noble gas is permitted to flow out of the instrument before the high-frequency source for ionizing the noble gas is switched on, thereby reducing the concentration of combustible substances near a biological tissue to be treated and thus avoiding the ignition of the combustible substances,

wherein the control means controls the flow rate of the noble gas from the noble gas source to the instrument such that the flow rate is higher after activation of the apparatus but before the high-frequency source is switched on than it is after the high-frequency source has been turned on during an argon-plasma coagulation procedure.

18. A apparatus according to claim 17, wherein the control means can be adjusted in advance to control the amount of the noble gas that flows out of the argon-plasma coagulation instrument before the high-frequency source is switched on.

19. An apparatus according to claim 17, wherein the control means is adapted to control the flow rate of the noble gas from the noble gas source to the instrument before the high-frequency source is switched on, wherein the flow rate is dependent on relevant boundary conditions.

20. An apparatus according to claim 17, wherein the control means is adapted to adjust the amount of the noble gas that can flow out of the argon-plasma coagulation instrument before the high-frequency source is switched on, where the amount of the noble gas is dependent on a length of a pause between two periods of activation of the instrument and a length of preceding periods of activation of the instrument.

21. An apparatus according to claim 17, comprising signaling means for generating a signal which informs the user that the high-frequency source is not turned on during a time interval between activation of the apparatus for coagulation and a turning on of the high-frequency source.

22. An apparatus according to claim 17, wherein the control means is adapted to prevent the high-frequency source from being turned on until the specified amount of the noble gas has flowed out of the argon-plasma coagulation instrument.